Naturalendo Tech Co

Naturalendo Tech Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Naturalendo Tech Co (168330.KQ) as of Nov 13, 2026 is -8.31 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -5.77 B KRW — a change of 44.06% (lower).

EBITDA

-8.31 BKRW

YoY

44.06%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Naturalendo Tech Co is 2022 -8.31 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Naturalendo Tech Co was 2021 -5.77 B KRW. It decreases by 44.06% lower compared to the previous year.

The Naturalendo Tech Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2015
-10.13 B KRW
Jan 1, 2016
-10.67 B KRW
Jan 1, 2017
-4.91 B KRW
Jan 1, 2018
-12.96 B KRW
Jan 1, 2019
-11.74 B KRW
Jan 1, 2020
-95.00 M KRW
Jan 1, 2021
-5.77 B KRW
Jan 1, 2022
-8.31 B KRW
The Naturalendo Tech Co EBITDA history
YEAREBITDAYoY
-8.31 BKRW+44.06%
-5.77 BKRW+5,974.72%
-95.00 MKRW-99.19%
-11.74 BKRW-9.47%
-12.96 BKRW+164.29%
-4.91 BKRW-54.03%
-10.67 BKRW+5.31%
-10.13 BKRW-138.41%
26.38 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Naturalendo Tech Co Stock analysis

What does Naturalendo Tech Co do? Naturalendo Tech Co., Ltd. generates revenue by engaging in the physical, chemical, and biological research and development of healthcare materials, specifically focusing on hormone biotechnology products. The Korea-based company manufactures novel phytoestrogen, which is applied in the treatment of climacteric, as well as other hormonal formulas including hormone disruptor inhibitors, secretagogues, and inhibitors used as diet formulas and growth hormone. The firm also provides materials used for diet and involves itself in the research and development of drug delivery systems, immune enhancers, and treatments for atopy and acne. The company further monetizes its expertise by developing solutions for plantation factories and other related areas within the healthcare sector. Headquartered in Seongnam, Gyeonggi-Do, Naturalendo Tech Co., Ltd. serves clients seeking advanced biotechnology applications in dietary and medical treatments. The business model relies on its proprietary R&D capabilities to produce specialized hormonal and dietary materials, catering to the demand for innovative healthcare solutions in the biotechnology industry. Naturalendo Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Naturalendo Tech Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Naturalendo Tech Co is -8.31 B KRW in 2022.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Naturalendo Tech Co changed from -5.77 B KRW to -8.31 B KRW, representing a 44.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Naturalendo Tech Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Naturalendo Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Naturalendo Tech Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Naturalendo Tech Co